XML 69 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Statements of Income (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Net sales $ 2,175,044us-gaap_SalesRevenueNet $ 2,132,694us-gaap_SalesRevenueNet $ 2,069,235us-gaap_SalesRevenueNet
Cost of goods sold 996,527us-gaap_CostOfGoodsSold 954,216us-gaap_CostOfGoodsSold 914,077us-gaap_CostOfGoodsSold
Gross profit 1,178,517us-gaap_GrossProfit 1,178,478us-gaap_GrossProfit 1,155,158us-gaap_GrossProfit
Selling, general and administrative expense 808,200us-gaap_SellingGeneralAndAdministrativeExpense 798,070us-gaap_SellingGeneralAndAdministrativeExpense 681,778us-gaap_SellingGeneralAndAdministrativeExpense
Research and development expense 220,333us-gaap_ResearchAndDevelopmentExpense 210,952us-gaap_ResearchAndDevelopmentExpense 209,204us-gaap_ResearchAndDevelopmentExpense
Income from operations 149,984us-gaap_OperatingIncomeLoss 169,456us-gaap_OperatingIncomeLoss 264,176us-gaap_OperatingIncomeLoss
Interest expense 22,131us-gaap_InterestExpense 61,271us-gaap_InterestExpense 51,112us-gaap_InterestExpense
Foreign exchange losses, net 9,305us-gaap_ForeignCurrencyTransactionGainLossBeforeTax 8,566us-gaap_ForeignCurrencyTransactionGainLossBeforeTax 5,040us-gaap_ForeignCurrencyTransactionGainLossBeforeTax
Other (income) expense, net (13,009)us-gaap_OtherNonoperatingIncomeExpense (12,766)us-gaap_OtherNonoperatingIncomeExpense (21,883)us-gaap_OtherNonoperatingIncomeExpense
Income before income taxes 131,557us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments 112,385us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments 229,907us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Provision for income taxes (42,712)us-gaap_IncomeTaxExpenseBenefit (34,574)us-gaap_IncomeTaxExpenseBenefit (64,361)us-gaap_IncomeTaxExpenseBenefit
Net income including noncontrolling interests 88,845us-gaap_ProfitLoss 77,811us-gaap_ProfitLoss 165,546us-gaap_ProfitLoss
Net loss (income) attributable to noncontrolling interests 0us-gaap_NetIncomeLossAttributableToNoncontrollingInterest (21)us-gaap_NetIncomeLossAttributableToNoncontrollingInterest (69)us-gaap_NetIncomeLossAttributableToNoncontrollingInterest
Net income attributable to Bio-Rad $ 88,845us-gaap_NetIncomeLoss $ 77,790us-gaap_NetIncomeLoss $ 165,477us-gaap_NetIncomeLoss
Basic earnings per share:      
Net income per share basic attributable to Bio-Rad $ 3.08us-gaap_EarningsPerShareBasic $ 2.72us-gaap_EarningsPerShareBasic $ 5.85us-gaap_EarningsPerShareBasic
Weighted average common shares - basic 28,876us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 28,586us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 28,290us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
Diluted earnings per share:      
Net income per share diluted attributable to Bio-Rad $ 3.05us-gaap_EarningsPerShareDiluted $ 2.69us-gaap_EarningsPerShareDiluted $ 5.78us-gaap_EarningsPerShareDiluted
Weighted average common shares - diluted 29,133us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 28,906us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 28,642us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding